Prénatal : DPN, DPI (P605 – P651)

Publisher： Edp Sciences

E-ISSN： 1958-5381|26|issue|223-237

ISSN： 0767-0974

Source： Médecine/sciences, Vol.26, Iss.issue, 2011-09, pp. : 223-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Développement et diagnostic prénatal (P140 – P175)

By  

Médecine/sciences, Vol. 24, Iss. issue, 2011-09 ,pp. : 76-89

Edp Sciences

Access to resources Recommend Favorite

Bronchoprotective and Bronchodilator Effects of an HFA pMDI vs. a CFC pMDI and a DPI Containing Formoterol in Asthma Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 35-37

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Efficacy Crossover Trial Comparing Formoterol-HFA (pMDI) versus Formoterol-DPI (AerolizerTM) and Placebo (pMDI or AerolizerTM) in Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 6-12

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Safety Crossover Trial Comparing Cumulative Doses up to 96 μg of Formoterol Delivered via an HFA-134a-Propelled pMDI vs. Same Cumulative Doses of Formoterol DPI and Placebo in Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 28-34

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Crossover Trial Evaluating the Efficacy and Safety Profiles of Two Dose Levels (12 and 24 μg) of Formoterol-HFA (pMDI) vs. Those of a Dose Level (24 μg) of Formoterol-DPI (Foradil®/Aerolizer™) and of Placebo (pMDI or Aerolizer) in Moderate to Severe Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 13-19

Karger

Access to resources Recommend Favorite